Assess outcomes and psychological change

The manuals converge on the need to assess change over time using both symptom measures and patient-reported experience. Across the extracts, anxiety and depression are tracked before and after treatment, with follow-up used to see whether effects persist or shift. The LSD-assisted psychotherapy source and the ayahuasca source both explicitly refer to structured outcome measures and pre to post comparisons, while the ibogaine manual also frames mood and affect monitoring as part of recovery over months. They also overlap in treating subjective change as part of outcome assessment, not just symptom scores. The LSD-assisted psychotherapy source mentions qualitative, client-centred inquiry into subjective experience, life changes, quality of life, attitudes, values, and psychopathology over time. The ibogaine manual similarly notes emotional distress, dysphoria, and anxiety during integration and follow-up, which points to attention to lived experience alongside symptom monitoring. The sources differ in emphasis and scope. The ibogaine manual is more focused on monitoring mood risks and possible delayed effects, including worsening symptoms and escalation if there is significant clinical risk. By contrast, the LSD-assisted psychotherapy source is broader and more explicitly longitudinal, combining standardised anxiety inventories with qualitative interviews and tracking state and trait anxiety.